Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with I g G 1 antibody in patients with gastric or colorectal cancer-Reference-Cited by-同舟云学术

Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with I g G 1 antibody in patients with gastric or colorectal cancer

Published:2018-02-14 Issue:12 Volume:142 Page:2599-2609
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ishikawa Takeshi¹^ORCID,Okayama Tetsuya¹,Sakamoto Naoyuki¹^ORCID,Ideno Mitsuko²,Oka Kaname¹,Enoki Tatsuji²,Mineno Junichi²,Yoshida Naohisa¹,Katada Kazuhiro¹,Kamada Kazuhiro¹,Uchiyama Kazuhiko¹,Handa Osamu¹,Takagi Tomohisa¹,Konishi Hideyuki¹,Kokura Satoshi¹,Uno Kazuko³,Naito Yuji¹,Itoh Yoshito¹

Affiliation:

1. Department of Gastroenterology and HepatologyGraduate School of Medical Science, Kyoto Prefectural University of MedicineKyoto Japan

2. CDM Center, Takara Bio Inc.Kusatsu Japan

3. Division of Basic ResearchLouis Pasteur Center for Medical ResearchKyoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31285